Hypersensitivity Clinical Trial
Official title:
A Pilot Study to Evaluate the Efficacy of Refined Methods to Mitigate Indoor Allergens in North Carolina and Boston, Massachusetts Homes
Verified date | September 11, 2006 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
A Pilot Study to Evaluate the Efficacy of Refined Methods to Mitigate Indoor Allergens in North Carolina and Boston, Massachusetts Homes
Status | Completed |
Enrollment | 88 |
Est. completion date | September 11, 2006 |
Est. primary completion date | |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 21 Years and older |
Eligibility |
- INCLUSION CRITERIA: To be eligible for the study, each home must: 1. have a home occupant who intends to live at the same address for at least 6 months; 2. have a home occupant live at the house full time; 3. have a home occupant that is at least 21 years of age; 4. have at least one bedroom with wall to wall carpeting. 5. Yield dust collected during the screening visit that contains combined Der f I plus Der p I allergen levels of greater than or equal to 10 ug/gram dust. For the intervention arm only: 6. home occupant must have an adult at home during the study visits on weekdays over the six month period that the study is ongoing. EXCLUSION CRITERIA: Homes will be excluded from this study if any of the inclusion criteria are not met. Indoor Dust Mite Allergen: Must have a home occupant who intends to live at the same address for at least 6 months; live at the house full time; be at least 21 years of age; have at least one bedroom with wall to wall carpeting; yield dust collected during the screening visit that contains combined Def fl plus Der pl allergen levels of greater than or equal to 10 ug/gram dust. For Intervention arm only - home occupant must have an adult at home during the study visits on weekdays over the six month period that the study is ongoing. Indoor Cockroach Allergen: Must have a home occupant that intends to live at the same address for at least 6 months; live in the house full time; be at least 21 years of age; have moderate to severe cockroach infestation as evidenced by occupant self-reports of cockroach sightings and by sticky trap assessment that yield a combined total sticky trap count of 50-250 cockroaches. For intervention arm only - home occupant must have an adult at home during most of the weekdays over the six month period that the study is ongoing. |
Country | Name | City | State |
---|---|---|---|
United States | National Institute of Environmental Health Sciences (NIEHS) | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Institute of Environmental Health Sciences (NIEHS) |
United States,
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04531540 -
Study to Determine Skin Irritation and/or Sensitization Potential of an Antifungal Cream Containing Trolamine (Repeated Insult Patch Test)
|
Phase 3 | |
Completed |
NCT00988065 -
Sugammadex Hypersensitivity Study (Study P06042)
|
Phase 1 | |
Completed |
NCT03563066 -
Effect of Benralizumab in Atopic Dermatitis
|
Phase 2 | |
Completed |
NCT02588326 -
Sensitivity of Pharmacokinetics to Differences in Particle Size Distribution of Suspension-based Nasal Sprays
|
Phase 1 | |
Completed |
NCT02916888 -
A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists
|
N/A | |
Completed |
NCT02352168 -
Airway Inflammation in Children With Allergic Rhinitis and Intervention
|
N/A | |
Completed |
NCT02360072 -
Airway Inflammation and Bronchial Hyperresponsiveness in Rhinitic Children With or Without Asthma
|
||
Completed |
NCT01904604 -
Peanut Epicutaneous Phase II Immunotherapy Clinical Trial
|
Phase 2 | |
Completed |
NCT01494649 -
Pilot Study to Investigate the Efficacy of a Toothpaste in Providing Relief From Dentinal Hypersensitivity
|
N/A | |
Enrolling by invitation |
NCT05039229 -
Measures for Bioaerosol Reduction in the Salmon Industry
|
N/A | |
Enrolling by invitation |
NCT05675241 -
Characterizing the Inflammation Around Dental Implants
|
||
Completed |
NCT04006106 -
Defining ENDOtypes in Perioperative Hypersensitivity by Extensive Cellular and Molecular PHENotyping (ENDOPHEN)
|
||
Not yet recruiting |
NCT06065137 -
Standardised Drug Provocation Testing in Perioperative Hypersensitivity
|
Phase 4 | |
Completed |
NCT04605471 -
A Study to Learn More About the Safety of Ultravist in Children and in the Elderly
|
||
Completed |
NCT03720470 -
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
|
Phase 3 | |
Terminated |
NCT05247567 -
Quaternary Ammonium and Immunization in Hairdressers
|
N/A | |
Completed |
NCT05119751 -
Vestibular Versus Sublingual Route of AIT Tablets
|
Phase 4 | |
Recruiting |
NCT05960266 -
Immunological Analysis of Lymph Node Tissue After Intralymphatic Immunotherapy: A Prospective Case Control Study
|
Early Phase 1 | |
Not yet recruiting |
NCT04485299 -
Clinical Assessment of Bifluorid 10 vs Varnish Fluoride on The Exposed Hypersensitive Cervical Dentin in Adult Patient
|
Phase 2/Phase 3 | |
Completed |
NCT02686827 -
DBPC-Dose-finding-trial of Vitamin D3 for SCIT in Birch Pollen Allergic Patients.
|
Phase 2 |